• Product NameAmprenavir
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityAmprenavir is a potent PXR-selective agonist, and an HIV protease inhibitor, used to treat HIV.
• Target NameHIV Protease inhibitor
• CAS No. 161814-49-9
• Calculated MW 505.63
• Formulation C25H35N3O6S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1 |r,c:12,14,35,t:10,30,32|
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:HIV protease
  Boling pt:
  Melting pt:
  Solubility:DMSO:16 mg/mL (31.64 mM)Ethanol:100 mg/mL (197.77 mM)Water:<1 mg/mL (<1 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Helsley RN, et al. Mol Pharmacol,?013, 83(6), 1190-1199.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting